معرفی
Dr Evelyn Lee is a health economist and research fellow at the University of Sydney's Sydney School of Public Health, Faculty of Medicine and Health, and is affiliated with the Leeder Centre for Health Policy, Economics and Data. She completed her PhD in Economics at UNSW Sydney and her undergraduate studies in Economics at the National University of Singapore. She serves as an Associate Editor for Addiction and Scientific Reports, and as an Editor for Paediatrics and Child Health. She is a member of the NSW Population and Health Services Research Ethics Committee and a councillor for the Economic Society of Australia (NSW Branch).
Education:
- PhD in Economics, UNSW Sydney
- Bachelor of Economics, National University of Singapore
Research Interests:
Dr Lee's research focuses on the intersection of economics and health policy, particularly in the use of large-scale linked datasets to evaluate healthcare costs and outcomes. She develops simulation models to assess cost-effectiveness and equity impacts of health interventions, with a strong emphasis on neonatal and perinatal health, genetic carrier screening, and population-based screening strategies.
Her recent work explores the long-term economic burden of prenatal substance exposure, the cost-effectiveness of expanded reproductive carrier screening, and the impact of neonatal interventions such as inhaled nitric oxide and virtual wards for infants with bronchopulmonary dysplasia.
Scientific Awards & Recognition:
- 2024: Visiting Fellow, University of York, UK
- 2022–2024: Macquarie University Research Fellowship Recipient
- 2017: Best Oral Presentation, 7th Congress of the Asian Pacific Initiative Reproductive Conference
Teaching & Supervision:
Dr Lee teaches Quantitative Methods in Economics, Business and Finance and currently supervises four PhD students researching topics such as the economic impact of parental mental illness on children, long-term outcomes of preterm infants, and the economic burden of pediatric RSV disease.
Grants & Projects:
She leads or co-leads several major grants including the 2022–2025 MRFF-funded Lungs for Life project (A$1.9M) evaluating virtual wards for infants with bronchopulmonary dysplasia, and the 2026–2028 NHMRC Partnership for Cancer Research as lead CI for economic modeling.
